University of Michigan researchers have developed an implantable system that could predict type 1 diabetes before symptoms appear. By tracking subtle changes in the immune system, the device may help doctors know when to intervene. The findings point to a future where high-risk individuals can be monitored more closely, though the full impact is still unfolding.
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.